What Is Thymalin? Dosage, Half-Life & How to Track It

What Thymalin is and how it works

Thymalin is a multi-peptide extract, not a single defined molecule — it is a mixture of short peptides (roughly 1–10 kDa) pulled from the thymus glands of young calves, developed by Russian researcher Vladimir Khavinson in the 1970s. That composition is a genuine double-edged sword: it may carry broad-spectrum thymic signaling that no single synthetic peptide replicates, but it also means batch-to-batch consistency is inherently harder to guarantee than with a fully synthetic compound.

Mechanistically, its peptides are small enough to cross into the cell nucleus and bind DNA directly, modulating gene expression in immune cells — a different mode of action from the surface-receptor signaling most hormones use. The practical effect is restoring the thymus’s core job: turning immature T-cell precursors into functional T-cells and rebuilding IL-2 production, both of which decline sharply with age as the thymus itself shrinks roughly 3% per year after age 30.

Worth being precise on naming, because this is the single most common sourcing mistake in this category: Thymalin is not the same as Thymulin (a defined nine-amino-acid hormone requiring zinc as a cofactor) or Thymosin Alpha-1 (a single synthetic 28-amino-acid peptide). All three get grouped together informally, but they are structurally distinct compounds with separate evidence bases.

Typical dosing & reconstitution

Thymalin is used in short, intensive cycles rather than continuous daily dosing — a deliberate design choice meant to preserve receptor responsiveness rather than blunt it with constant exposure. The Khavinson protocol calls for 10 mg per day, injected subcutaneously or intramuscularly, for 10 consecutive days, repeated once or twice a year.

A single 5 mg vial only holds a 5 mg dose (100 units) — reaching the full 10 mg protocol dose from 5 mg vials at 5 mg/mL takes 2 mL, i.e., two vials. Vials also contain non-peptide excipients (mannitol, acetic acid), so labeled vial weight is not purely peptide content. The calculator handles the concentration math regardless of source.

Half-life & what it means for the dosing pattern

Because Thymalin is a mixture of several short peptides rather than one defined molecule, its plasma half-life is not precisely characterized the way a single peptide’s would be — what is understood is that, like most unmodified short peptides, clearance is fast, on the order of minutes to a couple of hours per component.

That short clearance is part of why the protocol is a 10-day burst, not a daily-forever regimen: the intent is to deliver a concentrated pulse of thymic signaling, then let the body respond over the following months, rather than to maintain a constant blood level the way a long-half-life compound would.

What to track & who it fits

Reported side effects are mild — injection-site irritation, more common with intramuscular than subcutaneous, and transient fatigue or low-grade fever in the first day or two of a cycle, read by the community as a sign of immune activation rather than a problem. Thymalin has hard contraindications: active autoimmune disease, organ-transplant immunosuppression, and active lymphoma or leukemia, since amplifying immune activity is the opposite of what those conditions need.

The human mortality data comes entirely from adults averaging 71–77 years old — the rationale is meaningfully weaker for someone under 40 with a functioning immune system. What is worth tracking, especially for older users, is the 10-day cycle itself (easy to lose track of mid-course) and, if you lab it, T-cell subsets or a basic CBC before and after a cycle.

Frequently asked questions